Studies of a novel photosensitizer Pd-bacteriopheophorbide (Tookad®) for the prostate cancer PDT in canine model

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 5254, Issue , 2003, Pages 83-90

  Huang, Zheng ^a   Chen, Qun ^a   Brun, Pierre Herve ^b   Wilson, Brian C ^c   Scherz, Avigdor ^d   Salomon, Yoram ^d   Luck, David ^a   Beckers, Jill ^a   Hetzel, Fred W ^a  

^a Highlands Presbyterian St Luke's Podiatric Medicine and Surgery Residency Program   (United States)

^b STEBA Biotech   (France)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Pharmocokinetics; Photodynamic therapy; Prostate cancer; Tissue response; Vascular effects

Indexed keywords

BACTERIA; DRUG DOSAGE; DRUG INFUSION; DRUG PRODUCTS; HORMONES; OPTICAL BEAM SPLITTERS; PATIENT TREATMENT; PHARMACOKINETICS; PHOTODYNAMIC THERAPY; PHYSIOLOGICAL MODELS; RADIOTHERAPY; TISSUE; TUMORS;

PROSTATE CANCERS; TISSUE RESPONSE; VASCULAR EFFECTS;

PHOTOSENSITIZERS;

EID: 1842581710     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.546099     Document Type: Conference Paper

References (24)

1. Boyle P. Prostate cancer 2000: Evolution of an epidemic of unknown origin; in Prostate Cancer 2000, Ed. L. Denis, Springer-Verlag, Herdelberg, 5-11, 2001.
2. Catalona W. J. (1994) Management of cancer of the prostate. New Eng. J. Med. 331:996-1004.
3. Stamey T.A. (1993) Irradiation as primary treatment for prostate cancer. Am. Urol. Assoc. Today 6:14.
4. Onik G. (2001) Image-guided prostate cryosurgery: state of the art. Cancer Control 8:522-531.
5. Yerushalmi A. (1998) Localized non-invasive deep microwave hyperthermia for the treatment of prostatic tumours: the first 5 years. In "Application of hyperthermia in the treatment of cancer" Ed. by R. D. Issels and W. Wilmanns, Berlin, Springer Verlag, p 141.
6. Gelet A., J. Y. Chapelon, R. Bouvier, O. Rouviere, D. Lyonnet and J. M. Dubernard (2001) Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur. Urol. 40:124-192.
7. Vallancien G., et al., (1991) Focused extracorporeal pyrotherapy: experimental results. Eur., Urol. 20:211-219.
8. Chaussy C. and S. Thuroff (2001) Results and side effects of high-intensity focused untrasound in localized prostate cancer. J. Endourol. 15:437-440.
9. Chen Q., Z. Huang, D. Luck, J. Beckers, P. Brun, B. C. Wilson, A. Scherz, Y. Salomon and F. W. Hetzel (2002) WST09 (TOOKAD) mediated photodynamic therapy as an alternative modality in treatment of prostate cancer. Proc. SIPE. 4612:29-39.
10. Chen Q., Z. Huang, D. Luck, J. Beckers, P. Brun, B. Wilson, A. Scherz, Y. Salomon, F. Hetzel (2002) Preclinical studies in normal canine prostate of a novel Palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. Photochem. Photobiol. 76:88-95.
11. Chen Q. and F. W. Hetzel (1998) Laser dosimetry studies in the prostate. J. Clin. Laser Med. Surg. 16:9-12.
12. Chen Q., B. C. Wilson, S. D. Shetty, M. S. Patterson, J. C. Cerny and F. W. Hetzel (1997) Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat. Res. 147:86-91.
13. Lee L. K., C. Whitehurst, M. L. Pantelides and J. V. Moore (1995) Interstitial photodynamic therapy in the canine prostate. Br. J. Urol. 80:898-902.
14. Selman S. H., R. W. Keck and J. A. Hampton (1996) Transperineal photodynamic ablation of the canine prostate. J. Urol. 156:258-260.
15. Selman S. H., D. Albrecht, R. W. Keck, P. Brennan and S. Kondo (2001) Studies of Tin ethyl etiopurpurin photodynamic therapy of the canine prostate. J. Urol. 165:1795-1801.
16. Chang S., G. A. Buonaccorsi, A. J. MacRobert and S. G. Bown (1997) Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX. The Prostate 32:89-98.
17. Chang S., G. Buonaccorsi, A. MacRobert and S. G. Bown (1996) Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin. Int. J. Cancer 67:555-562.
18. Hsi R. A., A. Kapatkin, J. Strandberg, T. Zhu, T. Vulcan, M. Solonenko, C. Rodriguez, J. Chang, M. Saunders, N. Mason and S. Hahn (2001) Photodynamic therapy in the canine prostate using motexafin lutstium. Clin. Cancer Res. 7:6651-660.
19. Sheeham D. C. and B. B. Hrapchak (1987) Theory and Practice of Histotechnology, pp. 196-197.
20. Windahl T, S. O. Andersson and L. Lofgren (1990) Photodynamic therapy of localized prostatic cancer (letter). Lancet 336: 1139.
21. Whitehurst C, M. L. Pantelides, J. V. Moore, P. J. Brooman and N. J. Blacklock. (1994) In vivo laser light distribution in human prostatic carcinoma. J. Urol. 151:1411-1415.
22. Nathan T. R., D. E. Whitelaw, S. C. Chang, W. R. Lees, P. M. Ripley, H. Payne, L. Jones, M. C. Parkinson, M. Emberton, A. R. Gillams, A. R. Mundy and S. G. Bown. (2002) Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J. Urol. 168:1427-1432.
23. Zilberstein J., S. Schreiber, M.C. Bloemers, P. Bendel, M. Neeman, E. Schechtman, F. Kohen, A. Scherz and Y. Salomon (2001) Anti vascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy. Photochem. Photobiol. 73:257-263.
24. Bourre L., S. Thibaut, A. Briffaud, N. Rousset, S. Eleouet, Y. Lajat, and T. Patrice (2002) Indirect detection of photosensitizer ex vivo. J Photochem Photobiol B. 67:23-31.